Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
KLASS, 48% Increase in Ordinary Profit for The Current Fiscal Year
6233 KLASS Corporation 【J-GAAP】
Earnings ReportKLASS Corporation <6233> [TSE Std] announced its financial results after the market closed on November 14th (15:35). The consolidated ordinary profit for the fiscal year ended September 2025 increased by 2.2 times that of the previous period to 250 million yen. For the fiscal year ending September 2026, the consolidated ordinary profit is expected to expand to 48.0% to 370 million yen.
In the most recent three-month period, from July to September (4Q), the consolidated ordinary profit decreased to 34 million yen, an 8.1% decrease compared to the same period last year. However, the operating profit margin remained almost flat, changing from 1.5% in the same period last year to 1.8%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep, 2023 | 9,888 | 314 | 283 | 102 | 19.0 | 10 | Nov 15, 2023 | J-GAAP |
| Sep, 2024 | 9,781 | 115 | 112 | 76 | 14.2 | 10 | Nov 15, 2024 | J-GAAP |
| Sep, 2025 | 9,569 | 267 | 250 | 172 | 32.1 | 10 | Nov 14, 2025 | J-GAAP |
| YoY | -2.2% | +132.2% | +123.2% | +126.3% | +127.0% |
Full Year Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep, 2025 Guidance | 10,150 | 355 | 350 | 220 | 40.8 | 10 | May 15, 2025 | J-GAAP |
| Sep, 2025 Results | 9,569 | 267 | 250 | 172 | 32.1 | 10 | Nov 14, 2025 | J-GAAP |
| Revision Rate | -5.7% | -24.8% | -28.6% | -21.8% | -21.3% |
Current Period Guidance
H1 Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 4,939 | 261 | 240 | 172 | 32.1 | 0 | May 15, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | ー | ー | ー | ー | - | 0 | Nov 14, 2025 | J-GAAP |
| YoY | - | - | - | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep, 2024 | 9,781 | 115 | 112 | 76 | 14.2 | 10 | Nov 15, 2024 | J-GAAP |
| Sep, 2025 | 9,569 | 267 | 250 | 172 | 32.1 | 10 | Nov 14, 2025 | J-GAAP |
| Sep, 2026 Guidance | 11,000 | 380 | 370 | 235 | 45.3 | 10 | Nov 14, 2025 | J-GAAP |
| YoY | +15.0% | +42.3% | +48.0% | +36.6% | +41.0% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Sep, 2024 | 2,656 | 41 | 37 | 41 | 7.6 | 1.5 | Nov 15, 2024 | J-GAAP |
| Oct - Dec, 2024 | 2,146 | 17 | 5 | 2 | 0.6 | 0.8 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 2,793 | 244 | 235 | 170 | 31.7 | 8.7 | May 15, 2025 | J-GAAP |
| Apr - Jun, 2025 | 2,170 | -39 | -24 | -23 | -4.3 | -1.8 | Aug 8, 2025 | J-GAAP |
| Jul - Sep, 2025 | 2,460 | 45 | 34 | 23 | 4.3 | 1.8 | Nov 14, 2025 | J-GAAP |
| YoY | -7.4% | +9.8% | -8.1% | -43.9% | -43.6% |
Related Articles
Yamaichi Uniheim Real Estate, First Half Ordinary Profit Turns to Loss, Jul-Sep Ordinary Profit Turns to Loss
LUCKLAND, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 2.2 times, Exceeded Record Profit Forecast, The Undecided Dividend Set at 20 Yen, Resuming Dividends for the First Time in Three Terms
AIMECHATEC, Jul-Sep (1Q) Ordinary Profit Turns to Profit
Delta-Fly Pharma, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens
Future Innovation Group, Jan-Sep (Cumulative 3Q) Ordinary Profit Increases by 87%, Jul-Sep Ordinary Profit Increases by 5.8 times
Giken Holdings, First Half Ordinary Profit Increases by 51%, Jul-Sep Ordinary Profit Increases by 2.1 times
BrightPath Biotherapeutics, First Half Net Income Loss Narrows, Jul-Sep Net Income Loss Widens
VELTRA, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 77%
LIFE CREATE, First Half Ordinary Profit Turns to Loss
CRESTEC, Jul-Sep (1Q) Ordinary Profit Increases by 2.5 times